Adamas Pharmaceuticals Careers in San Francisco, CA

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) is driven to improve the lives of those affected by chronic disorders of the central nervous system (CNS). We seek to achieve this by modifying the pharmacokinetic (PK) profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products. Approximately 36 million people in the United States suffer from chronic CNS disorders. CNS diseases are frequently treated with multiple medications having different mechanisms of action with the goal of maximizing symptomatic benefits for patients. Existing CNS drugs often require frequent dosing and may have tolerability issues that limit the amount of the drug that can be taken each day. We believe that many CNS disorders could be better treated if the PK profiles of existing CNS drugs are altered to increase efficacy while maintaining tolerability and if these enhanced drugs are then combined with other existing CNS drugs to improve and streamline the management of these complicated con